beta-lactams has been researched along with cefditoren in 15 studies
| Studies (beta-lactams) | Trials (beta-lactams) | Recent Studies (post-2010) (beta-lactams) | Studies (cefditoren) | Trials (cefditoren) | Recent Studies (post-2010) (cefditoren) |
|---|---|---|---|---|---|
| 7,579 | 179 | 3,395 | 124 | 10 | 27 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (13.33) | 18.2507 |
| 2000's | 10 (66.67) | 29.6817 |
| 2010's | 1 (6.67) | 24.3611 |
| 2020's | 2 (13.33) | 2.80 |
| Authors | Studies |
|---|---|
| Nakanishi, T; Nasu, T; Nishino, T; Okamoto, K | 1 |
| Hanaki, H; Hiramatsu, K; Inaba, Y | 1 |
| Hasegawa, M; Kobayashi, I; Koyama, H; Matsuzaki, K; Nishiyama, T; Saika, T | 1 |
| Odagiri, S; Shimada, J; Takahashi, H; Watanuki, Y | 1 |
| Sakata, H | 1 |
| Ichimaru, T | 1 |
| Kaye, KM; Martin, SI | 1 |
| Aguilar, L; Alou, L; Coronel, P; Echeverría, O; Giménez, MJ; González, N; Prieto, J; Sevillano, D; Torrico, M | 1 |
| Ida, T; Kato, Y; Maebashi, K; Sanbongi, Y; Takahata, S | 1 |
| Biedenbach, DJ; Fritsche, TR; Jones, RN | 1 |
| Marco, JA; Naranjo, OR; Rodríguez de Castro, F; Violán, JS | 1 |
| Aguilar, L; Alou, L; Cafini, F; Coronel, P; Giménez, MJ; González, N; Prieto, J; Sevillano, D; Torrico, M | 1 |
| Aguilar, L; Alou, L; Cafini, F; García, E; Giménez, MJ; Navarro, A; Ramos-Sevillano, E; Rodríguez-Sosa, C; Sevillano, D; Yuste, J | 1 |
| Batchelder, HR; Lamichhane, G; Nuermberger, EL; Panthi, CM; Rimal, B; Story-Roller, E; Tabor, C; Townsend, CA | 1 |
| Coronel, P; Del Río, I; Domenech, M; Gimeno, M; González-Camacho, F; Lago, D; Llamosí, M; López Ruiz, B; Pérez-García, C; Sempere, J; Yuste, J | 1 |
2 review(s) available for beta-lactams and cefditoren
| Article | Year |
|---|---|
Beta-lactam antibiotics: newer formulations and newer agents.
Topics: Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; beta-Lactams; Cefepime; Cephalosporins; Ertapenem; Humans; Lactams; United States | 2004 |
New antimicrobial molecules and new antibiotic strategies.
Topics: Acetamides; Anti-Infective Agents; beta-Lactams; Cephalosporins; Community-Acquired Infections; Drug Design; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Ertapenem; Fluoroquinolones; Humans; Ketolides; Linezolid; Lipopeptides; Oxazolidinones; Pneumonia, Bacterial; Practice Guidelines as Topic | 2009 |
13 other study(ies) available for beta-lactams and cefditoren
| Article | Year |
|---|---|
[In vitro antibacterial activity of faropenem, a novel oral penem antibiotic, against enterohemorrhagic Escherichia coli O157 strains].
Topics: Amoxicillin; Ampicillin; Anti-Bacterial Agents; Bacterial Toxins; beta-Lactams; Cefdinir; Cephalosporins; Clarithromycin; Escherichia coli O157; Fosfomycin; Kanamycin; Lactams; Microbial Sensitivity Tests; Minocycline; Norfloxacin; Shiga Toxin 1 | 1999 |
[Investigation of the antibacterial activity of faropenem against Streptococcus pneumoniae].
Topics: Anti-Bacterial Agents; beta-Lactams; Cefaclor; Cephalosporins; Drug Resistance, Microbial; Lactams; Penicillin G; Penicillin Resistance; Streptococcus pneumoniae | 1999 |
[In vitro activity of faropenem against beta-lactamase producing clinical isolates].
Topics: Anti-Bacterial Agents; Bacteria; beta-Lactamases; beta-Lactams; Cefdinir; Cephalosporins; Drug Resistance, Microbial; Humans; Lactams; Microbial Sensitivity Tests | 2000 |
[Epidemiological study on patients with pneumococcal respiratory tract infection in a Japanese health facility during the past year].
Topics: Acute Disease; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactams; Cephalosporins; Chronic Disease; Clarithromycin; Community-Acquired Infections; Drug Therapy, Combination; Female; Humans; Lactams; Male; Middle Aged; Ofloxacin; Pneumococcal Infections; Respiratory Tract Infections; Streptococcus pneumoniae; Time Factors | 2001 |
[Comparative study on bacterial eradication rate and clinical efficacy of CDTR, CFPN, and FRPM for treatment of children with otitis media and lower respiratory tract infection due to Streptococcus pneumoniae and Haemophilus influenzae].
Topics: Ampicillin Resistance; Anti-Bacterial Agents; beta-Lactams; Cephalosporins; Child; Child, Preschool; Community-Acquired Infections; Haemophilus Infections; Haemophilus influenzae; Humans; Infant; Lactams; Otitis Media; Penicillin Resistance; Pneumococcal Infections; Respiratory Tract Infections; Retrospective Studies; Streptococcus pneumoniae; Treatment Outcome | 2001 |
[Study on Streptococcus pneumoniae isolated from infants in widely-separated primary care facilities in Japan].
Topics: Anti-Bacterial Agents; beta-Lactams; Cephalosporins; Child Day Care Centers; Child, Preschool; Drug Resistance, Bacterial; Humans; Infant; Japan; Lactams; Otitis Media; Penicillin G; Serotyping; Siblings; Streptococcus pneumoniae | 2001 |
Are beta-lactam breakpoints adequate to define non-susceptibility for all Haemophilus influenzae resistance phenotypes from a pharmacodynamic point of view?
Topics: Amoxicillin-Potassium Clavulanate Combination; Ampicillin Resistance; Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Cefuroxime; Cephalosporins; Computer Simulation; Drug Resistance, Bacterial; Haemophilus influenzae; Half-Life; Kinetics; Microbial Sensitivity Tests; Phenotype | 2007 |
Comparison of the efficacies of oral beta-lactams in selection of Haemophilus influenzae transformants with mutated ftsI genes.
Topics: Ampicillin; Bacterial Proteins; beta-Lactams; Carbapenems; Cefdinir; Cefprozil; Cephalosporins; Gene Transfer, Horizontal; Haemophilus influenzae; Mutation; Penicillin-Binding Proteins | 2008 |
Update of the activity of cefditoren and comparator oral beta-lactam agents tested against community-acquired Streptococcus pneumoniae isolates (USA, 2004-2006).
Topics: Anti-Bacterial Agents; beta-Lactams; Cephalosporins; Community-Acquired Infections; Drug Resistance, Bacterial; Humans; Microbial Sensitivity Tests; Respiratory Tract Infections; Streptococcus pneumoniae | 2008 |
Influence of different resistance traits on the competitive growth of Haemophilus influenzae in antibiotic-free medium and selection of resistant populations by different {beta}-lactams: an in vitro pharmacodynamic approach.
Topics: Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; beta-Lactams; Cefuroxime; Cephalosporins; Coculture Techniques; Colony Count, Microbial; Haemophilus influenzae; Humans; Microbial Sensitivity Tests; Selection, Genetic | 2009 |
Cefditoren and ceftriaxone enhance complement-mediated immunity in the presence of specific antibodies against antibiotic-resistant pneumococcal strains.
Topics: Acute-Phase Proteins; Animals; Anti-Bacterial Agents; Antibodies; beta-Lactams; Ceftriaxone; Cephalosporins; Complement Activation; Complement C1q; Complement C3c; Drug Resistance, Microbial; Egtazic Acid; Flow Cytometry; Humans; Immune System; Mice; Phagocytosis; Streptococcus pneumoniae | 2012 |
T405, a New Penem, Exhibits
Topics: Animals; Anti-Bacterial Agents; beta-Lactams; Cephalosporins; Humans; Imipenem; Meropenem; Mice; Microbial Sensitivity Tests; Mycobacterium Infections, Nontuberculous | 2022 |
Effect of pneumococcal conjugate vaccines and SARS-CoV-2 on antimicrobial resistance and the emergence of Streptococcus pneumoniae serotypes with reduced susceptibility in Spain, 2004-20: a national surveillance study.
Topics: Anti-Bacterial Agents; beta-Lactams; Cefotaxime; Cephalosporins; COVID-19 Drug Treatment; Drug Resistance, Bacterial; Erythromycin; Humans; Pandemics; Penicillins; Pneumococcal Infections; Pneumococcal Vaccines; SARS-CoV-2; Serogroup; Spain; Streptococcus pneumoniae; Vaccines, Conjugate | 2022 |